Chief Human Resources Officer

President

The week in pharma: action, reaction and insight – week to September 12

Revolution takes early stage cues for a phase III in pancreatic cancer

Revolution advances daraxonrasib to Phase III in pancreatic cancer

REVOLUTION Medicines

Senior Director, Global Insights

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Senior Director, Global Insights will lead a team to generate strategic insights from market research to drive business decisions and support the development of the RevMed portfolio.

VP, Talent Acquisition

Executive Director, Head of Talent Acquisition

Regional Insights and Engagement Director, Northeast

Senior Director, Analytics and Insights

Regional Insights & Engagement Director (West)

Sign up with Google

Sign in with Google